Retro Biosciences, Backed by Sam Altman, Seeks $1 Billion to Extend Human Lifespan by 10 Years
Funding Goal:
Retro Biosciences aims to raise $1 billion in a Series A funding round to extend the human lifespan by 10 years135.
Backed by Sam Altman:
The startup is backed by Sam Altman, the CEO of OpenAI, indicating significant support from a prominent figure in the tech industry123.
Biotechnology Focus:
Retro Biosciences focuses on biotechnology, specifically on cellular reprogramming, autophagy, and plasma-inspired therapeutics to enhance human health and longevity2.
Previous Funding:
The company has previously raised $180 million, indicating substantial interest and investment in its mission2.
Partnerships:
Retro Biosciences has partnered with Multiply Labs in an $85 million deal to advance cell therapy manufacturing for age-related diseases2.
Location and Founding:
The startup was founded in 2020 and is based in San Francisco, California2.
Sources:
1. https://inshorts.com/en/news/altman-backed-retro-bio-to-raise--1-billion-to-extend-human-life-1737884191759
2. https://www.cbinsights.com/company/retro-biosciences
3. https://www.sunrisegeek.com/post/retro-biosciences-supported-by-sam-altman-seeks-1-billion-to-increase-the-human-lifespan